Cargando…
Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China
There are limited studies on the prevalence and incidence of clinically diagnosed hypertrophic myocardiopathy (HCM) and its mortality in the Chinese population, and the projected population burden of HCM over the next decades. We collected data on HCM and its mortality from the Beijing Municipal Hea...
Autores principales: | Bai, Ying, Zheng, Jian-Peng, Lu, Feng, Zhang, Xi-Lin, Sun, Chang-Ping, Guo, Wei-Hua, Zou, Yi-Xi, Lip, Gregory Y. H., Shi, Xu-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637201/ https://www.ncbi.nlm.nih.gov/pubmed/36335106 http://dx.doi.org/10.1038/s41598-022-20042-9 |
Ejemplares similares
-
De Novo Asp219Val Mutation in Cardiac Tropomyosin Associated with Hypertrophic Cardiomyopathy
por: Tsaturyan, Andrey K., et al.
Publicado: (2022) -
Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany—An analysis of over 5 million patients
por: Husser, Daniela, et al.
Publicado: (2018) -
Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population
por: Lopes, Luis R., et al.
Publicado: (2021) -
Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study
por: Moon, Inki, et al.
Publicado: (2020) -
Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)